Targeted Medical (TRGM) 0.6590 $TRGM
Targeted Medical Pharma to Present at Sachs Associated 14th Annual Biotech in Europe Forum for Global Partnering and Investment
Business Wire - Tue Sep 16, 9:00AM CDT
Targeted Medical Pharma (OTCQB:TRGM), today announced that William Shell, M.D., Chairman, CSO and CEO is scheduled to present the latest company information regarding the advances in therapeutic nutrition and medical foods technology, at the 14th Annual Biotech in Europe Forum at the Congress Center in Basel, Switzerland. The presentation is scheduled for September 30th, 2014 at 11:45 am in the Lima Room. Dr. Shell will also be a panelist in the discussion regarding advancements in Neuroscience at 3:30 pm.
Targeted Medical Pharma, Inc. - "Welcome to the Targeted Medical Pharma Blog"
ACCESSWIRE - Mon Sep 15, 8:31AM CDT
New York, NY / September 15, 2014 / Targeted Medical Pharma, Inc. (OTCQB: TRGM) today published a new blog post on The Chairman's Blog, written by the Company's CEO and CSO, Dr. William Shell. TheChairmansBlog.com is an exclusive online media publication that enables key executive officers a unique platform to share insights about their company and industry trends.
Targeted Medical Pharma Reports Second Quarter 2014 Financial Results
Business Wire - Thu Aug 14, 4:30PM CDT
Targeted Medical Pharma, Inc. (OTCQB: TRGM), today announced financial results for its second quarter ended June 30, 2014. The Company posted increased revenues, gross profit and an increase in net income before interest, taxes, depreciation and amortization, and stock based compensation (Adjusted EBITDA*) on a quarter-over-quarter basis.
Targeted Medical Pharma Agrees to Sponsor a Clinical Trial Conducted by the United States Army and Henry M. Jackson Foundation for the Advancement of Military Medicine
Business Wire - Mon Jul 28, 10:21AM CDT
Targeted Medical Pharma, Inc. (OTCQB: TRGM), today announced the completion of an agreement to sponsor an investigator-initiated study with the United States Army and The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc. (HJF). The study, which is slated to start enrolling patients in Q2 of 2014, will involve the Company's medical food Theramine.
Tauriga Sciences enters into license agreement with Targeted Medical Pharma for launch of new cannabis complements product line
M2 - Thu Jul 17, 8:15AM CDT
Life sciences company Tauriga Sciences (Other OTC:TAUG) disclosed on Wednesday the launch of a non-exclusive licensing agreement under its "Cannabis Complements" product line.
Tauriga Sciences Inc. Signs License Agreement With Targeted Medical Pharma Inc.
GlobeNewswire - Wed Jul 16, 2:31PM CDT
Tauriga Sciences Inc. (OTCQB:TAUG) or ("Tauriga" or the "Company"
, a diversified life sciences company, announced today it has signed a non-exclusive licensing agreement with Targeted Medical Pharma Inc. (OTCQB:TRGM) to reformulate and rebrand Targeted Medical's medical food formulations into dietary supplements as part of Tauriga's "Cannabis Complements" product line. Tauriga's new Cannabis Complements product line will be formally launched later in the summer and consists of dietary supplements and other natural wellness products that do not contain cannabis oil and that will attempt to address cannabis-related effects, such as anxiety, memory and cognitive functions, and appetite control. The products to be offered under the "Cannabis Complements" line will contain "GRAS" ingredients, the U.S. Food and Drug Administration's designation for ingredients that are "Generally Recognized as Safe".
Targeted Medical Pharma Appoints Two New Independent Members to the Board of Directors
Business Wire - Thu Jun 12, 5:00PM CDT
Targeted Medical Pharma, Inc. (OTCQB: TRGM), today announced the addition of two independent members to the Company's board of directors. The Company welcomes back health care specialist Kerry Weems to the board as an independent director and chairman of the Nominating and Governance Committee, as well as corporate finance expert Paul Pelosi, Jr. as an independent director.
Targeted Medical Pharma Reports Fourth Quarter and Fiscal Year 2013 Financial Results
Business Wire - Mon Mar 31, 4:54PM CDT
Targeted Medical Pharma, Inc. (OTCQB: TRGM), today announced financial results for its fourth quarter and fiscal year ended December 31, 2013. The Company posted increased revenues, gross profit and a reduction in net loss before interest, taxes, depreciation and amortization, stock based compensation (Adjusted EBITDA*) on both a year-over-year and a quarterly basis.
Targeted Medical Pharma names Dr Thomas Wenkart to board
M2 - Tue Mar 11, 7:19AM CDT
US-based biotechnology company Targeted Medical Pharma (Other OTC:TRGM) revealed on Monday the addition of Dr Thomas Wenkart to its board of directors.
Healthcare Executive Dr. Thomas Wenkart Joins Targeted Medical Pharma's Board of Directors
Business Wire - Mon Mar 10, 10:59PM CDT
Targeted Medical Pharma, Inc. (OTCQB:TRGM) today announced that Dr. Thomas Wenkart, Chief Executive and Chairman at Macquarie Health Corporation, has joined the company's board of directors.
Targeted Medical Pharma signs promotion and distribution agreement for Clearwayz
M2 - Tue Feb 11, 7:06AM CST
US-based biotechnology company Targeted Medical Pharma Inc (Other OTC:TRGM) revealed on Monday the completion of a promotion and distribution agreement for Clearwayz using direct-response television commercials and internet promotion for select audiences in major markets.
Targeted Medical Pharma begins clinical trial of new medical food for Autism Spectrum Disorders, with impaired absorption and increased nutritional requirements
M2 - Mon Sep 02, 5:05AM CDT
Biotechnology company Targeted Medical Pharma Inc (OTC BB:TRGM) reported on Friday the start of a clinical trial of a new medical food indicated for the dietary management of Autism and Autism Spectrum Disorders.
OTC Daily Alert Stock Watch - Targeted Medical Pharma, Inc (OTCQB: TRGM)
WorldStockWire - Fri Aug 30, 7:45PM CDT
OTC Daily Alert tracks stocks daily and is pleased to offer features on public companies. Investors can receive FREE Stock Alerts and company news and profiles by visiting OTC Daily Alert at the following: http://www.otcdailyalert.com
Targeted Medical Pharma Inc forms dietary supplement division, with first market launch in November 2013
M2 - Fri Aug 30, 8:09AM CDT
Biotechnology company Targeted Medical Pharma Inc (OTC BB:TRGM) revealed on Thursday the establishment of a new division that will specialise in the manufacturing and distribution of a proprietary line of dietary supplements.
Targeted Medical Pharma Establishes Dietary Supplement Division
Business Wire - Thu Aug 29, 7:00AM CDT
Targeted Medical Pharma, Inc. (OTCQB: TRGM) (OTCBB: TRGM), a biotechnology company that develops and distributes prescription medical foods to physicians and pharmacies, today announced the launch of a new division that will specialize in the manufacturing and distribution of a proprietary line of dietary supplements.
Targeted Medical Pharma Inc appoints William B Horne as CFO
M2 - Thu Aug 22, 7:00AM CDT
Biotechnology company Targeted Medical Pharma Inc (OTC BB:TRGM) revealed on Wednesday the addition of William B Horne as its chief financial officer.
Targeted Medical Pharma Selects William B. Horne as Chief Financial Officer
Business Wire - Wed Aug 21, 4:56PM CDT
Targeted Medical Pharma, Inc. (OTCQB: TRGM), a biotechnology company that develops and distributes prescription medical foods, convenience kits and generic pharmaceuticals to physicians and pharmacies, today announced the appointment of William B. Horne as the company's Chief Financial Officer. He will oversee all aspects of the company's fiscal operations and financial reporting.
Targeted Medical Pharma Reports 2013 Second Quarter Financial Results
Business Wire - Wed Aug 14, 6:33PM CDT
Targeted Medical Pharma, Inc. (OTCQB:TRGM), a biotechnology company that develops and distributes prescription medical foods, convenience kits and generic pharmaceuticals to physicians and pharmacies, today announced financial results for its second quarter ended June 30, 2013. The Company continued to post increasing revenue for the second quarter and first half of 2013 compared to the second quarter and first half of 2012.
Targeted Medical Pharma to Present at 2013 Southern California Investor Conference
Business Wire - Tue Aug 06, 4:32PM CDT
Targeted Medical Pharma, Inc. (OTCQB: TRGM), a biotechnology company that develops and distributes prescription medical foods, convenience kits and generic pharmaceuticals to physicians and pharmacies for the treatment of chronic disease, today announced that the company's CEO and Chief Science Officer William Shell, M.D., will be presenting at the 2013 Southern California Investor Conference being held at the Island Hotel in Newport Beach, California on Thursday, August 8, 2013 at 8:30 a.m. PDT.
Targeted Medical Pharma Inc announces increase in use of prescription-only medical foods in Pacific Northwest and Hawaii
M2 - Thu Jul 18, 8:05AM CDT
Biotechnology company Targeted Medical Pharma Inc (OTC BB:TRGM) reported on Wednesday a rise in sales of its prescription-only medical foods in Pacific Northwest and Hawaii.
Targeted Medical Pharma to Present at Sachs Associated 14th Annual Biotech in Europe Forum for Global Partnering and Investment
Business Wire - Tue Sep 16, 9:00AM CDT
Targeted Medical Pharma (OTCQB:TRGM), today announced that William Shell, M.D., Chairman, CSO and CEO is scheduled to present the latest company information regarding the advances in therapeutic nutrition and medical foods technology, at the 14th Annual Biotech in Europe Forum at the Congress Center in Basel, Switzerland. The presentation is scheduled for September 30th, 2014 at 11:45 am in the Lima Room. Dr. Shell will also be a panelist in the discussion regarding advancements in Neuroscience at 3:30 pm.
Targeted Medical Pharma, Inc. - "Welcome to the Targeted Medical Pharma Blog"
ACCESSWIRE - Mon Sep 15, 8:31AM CDT
New York, NY / September 15, 2014 / Targeted Medical Pharma, Inc. (OTCQB: TRGM) today published a new blog post on The Chairman's Blog, written by the Company's CEO and CSO, Dr. William Shell. TheChairmansBlog.com is an exclusive online media publication that enables key executive officers a unique platform to share insights about their company and industry trends.
Targeted Medical Pharma Reports Second Quarter 2014 Financial Results
Business Wire - Thu Aug 14, 4:30PM CDT
Targeted Medical Pharma, Inc. (OTCQB: TRGM), today announced financial results for its second quarter ended June 30, 2014. The Company posted increased revenues, gross profit and an increase in net income before interest, taxes, depreciation and amortization, and stock based compensation (Adjusted EBITDA*) on a quarter-over-quarter basis.
Targeted Medical Pharma Agrees to Sponsor a Clinical Trial Conducted by the United States Army and Henry M. Jackson Foundation for the Advancement of Military Medicine
Business Wire - Mon Jul 28, 10:21AM CDT
Targeted Medical Pharma, Inc. (OTCQB: TRGM), today announced the completion of an agreement to sponsor an investigator-initiated study with the United States Army and The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc. (HJF). The study, which is slated to start enrolling patients in Q2 of 2014, will involve the Company's medical food Theramine.
Tauriga Sciences enters into license agreement with Targeted Medical Pharma for launch of new cannabis complements product line
M2 - Thu Jul 17, 8:15AM CDT
Life sciences company Tauriga Sciences (Other OTC:TAUG) disclosed on Wednesday the launch of a non-exclusive licensing agreement under its "Cannabis Complements" product line.
Tauriga Sciences Inc. Signs License Agreement With Targeted Medical Pharma Inc.
GlobeNewswire - Wed Jul 16, 2:31PM CDT
Tauriga Sciences Inc. (OTCQB:TAUG) or ("Tauriga" or the "Company"
, a diversified life sciences company, announced today it has signed a non-exclusive licensing agreement with Targeted Medical Pharma Inc. (OTCQB:TRGM) to reformulate and rebrand Targeted Medical's medical food formulations into dietary supplements as part of Tauriga's "Cannabis Complements" product line. Tauriga's new Cannabis Complements product line will be formally launched later in the summer and consists of dietary supplements and other natural wellness products that do not contain cannabis oil and that will attempt to address cannabis-related effects, such as anxiety, memory and cognitive functions, and appetite control. The products to be offered under the "Cannabis Complements" line will contain "GRAS" ingredients, the U.S. Food and Drug Administration's designation for ingredients that are "Generally Recognized as Safe". Targeted Medical Pharma Appoints Two New Independent Members to the Board of Directors
Business Wire - Thu Jun 12, 5:00PM CDT
Targeted Medical Pharma, Inc. (OTCQB: TRGM), today announced the addition of two independent members to the Company's board of directors. The Company welcomes back health care specialist Kerry Weems to the board as an independent director and chairman of the Nominating and Governance Committee, as well as corporate finance expert Paul Pelosi, Jr. as an independent director.
Targeted Medical Pharma Reports Fourth Quarter and Fiscal Year 2013 Financial Results
Business Wire - Mon Mar 31, 4:54PM CDT
Targeted Medical Pharma, Inc. (OTCQB: TRGM), today announced financial results for its fourth quarter and fiscal year ended December 31, 2013. The Company posted increased revenues, gross profit and a reduction in net loss before interest, taxes, depreciation and amortization, stock based compensation (Adjusted EBITDA*) on both a year-over-year and a quarterly basis.
Targeted Medical Pharma names Dr Thomas Wenkart to board
M2 - Tue Mar 11, 7:19AM CDT
US-based biotechnology company Targeted Medical Pharma (Other OTC:TRGM) revealed on Monday the addition of Dr Thomas Wenkart to its board of directors.
Healthcare Executive Dr. Thomas Wenkart Joins Targeted Medical Pharma's Board of Directors
Business Wire - Mon Mar 10, 10:59PM CDT
Targeted Medical Pharma, Inc. (OTCQB:TRGM) today announced that Dr. Thomas Wenkart, Chief Executive and Chairman at Macquarie Health Corporation, has joined the company's board of directors.
Targeted Medical Pharma signs promotion and distribution agreement for Clearwayz
M2 - Tue Feb 11, 7:06AM CST
US-based biotechnology company Targeted Medical Pharma Inc (Other OTC:TRGM) revealed on Monday the completion of a promotion and distribution agreement for Clearwayz using direct-response television commercials and internet promotion for select audiences in major markets.
Targeted Medical Pharma begins clinical trial of new medical food for Autism Spectrum Disorders, with impaired absorption and increased nutritional requirements
M2 - Mon Sep 02, 5:05AM CDT
Biotechnology company Targeted Medical Pharma Inc (OTC BB:TRGM) reported on Friday the start of a clinical trial of a new medical food indicated for the dietary management of Autism and Autism Spectrum Disorders.
OTC Daily Alert Stock Watch - Targeted Medical Pharma, Inc (OTCQB: TRGM)
WorldStockWire - Fri Aug 30, 7:45PM CDT
OTC Daily Alert tracks stocks daily and is pleased to offer features on public companies. Investors can receive FREE Stock Alerts and company news and profiles by visiting OTC Daily Alert at the following: http://www.otcdailyalert.com
Targeted Medical Pharma Inc forms dietary supplement division, with first market launch in November 2013
M2 - Fri Aug 30, 8:09AM CDT
Biotechnology company Targeted Medical Pharma Inc (OTC BB:TRGM) revealed on Thursday the establishment of a new division that will specialise in the manufacturing and distribution of a proprietary line of dietary supplements.
Targeted Medical Pharma Establishes Dietary Supplement Division
Business Wire - Thu Aug 29, 7:00AM CDT
Targeted Medical Pharma, Inc. (OTCQB: TRGM) (OTCBB: TRGM), a biotechnology company that develops and distributes prescription medical foods to physicians and pharmacies, today announced the launch of a new division that will specialize in the manufacturing and distribution of a proprietary line of dietary supplements.
Targeted Medical Pharma Inc appoints William B Horne as CFO
M2 - Thu Aug 22, 7:00AM CDT
Biotechnology company Targeted Medical Pharma Inc (OTC BB:TRGM) revealed on Wednesday the addition of William B Horne as its chief financial officer.
Targeted Medical Pharma Selects William B. Horne as Chief Financial Officer
Business Wire - Wed Aug 21, 4:56PM CDT
Targeted Medical Pharma, Inc. (OTCQB: TRGM), a biotechnology company that develops and distributes prescription medical foods, convenience kits and generic pharmaceuticals to physicians and pharmacies, today announced the appointment of William B. Horne as the company's Chief Financial Officer. He will oversee all aspects of the company's fiscal operations and financial reporting.
Targeted Medical Pharma Reports 2013 Second Quarter Financial Results
Business Wire - Wed Aug 14, 6:33PM CDT
Targeted Medical Pharma, Inc. (OTCQB:TRGM), a biotechnology company that develops and distributes prescription medical foods, convenience kits and generic pharmaceuticals to physicians and pharmacies, today announced financial results for its second quarter ended June 30, 2013. The Company continued to post increasing revenue for the second quarter and first half of 2013 compared to the second quarter and first half of 2012.
Targeted Medical Pharma to Present at 2013 Southern California Investor Conference
Business Wire - Tue Aug 06, 4:32PM CDT
Targeted Medical Pharma, Inc. (OTCQB: TRGM), a biotechnology company that develops and distributes prescription medical foods, convenience kits and generic pharmaceuticals to physicians and pharmacies for the treatment of chronic disease, today announced that the company's CEO and Chief Science Officer William Shell, M.D., will be presenting at the 2013 Southern California Investor Conference being held at the Island Hotel in Newport Beach, California on Thursday, August 8, 2013 at 8:30 a.m. PDT.
Targeted Medical Pharma Inc announces increase in use of prescription-only medical foods in Pacific Northwest and Hawaii
M2 - Thu Jul 18, 8:05AM CDT
Biotechnology company Targeted Medical Pharma Inc (OTC BB:TRGM) reported on Wednesday a rise in sales of its prescription-only medical foods in Pacific Northwest and Hawaii.
